Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4009 - 4016 of 11616 results
Coronavirus and Data Protection in the Workplace: The EDPB provides key guidance for companies with employees in Europe
March 23, 2020| Blog| Viewpoint
COVID-19 Texts from Health Care Providers Legal Under TCPA, FCC Confirms
March 23, 2020| News
UPDATED: Massachusetts Mandates Closure of All Non-Essential Businesses Effective Tuesday, March 24th at Noon
March 23, 2020| Blog| Viewpoint
Virtual Shareholder Meetings Permitted for NY Corporations through April 19
March 23, 2020| Blog| Viewpoint
Commercial Eviction Restrictions Take Shape Nationwide
March 23, 2020| Blog| Viewpoint
Mobilizing Against COVID-19: Emergency Responder and Military Leave
March 22, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.